HomeAMRX • NASDAQ
Follow
Amneal Pharmaceuticals Inc
Previous close
$6.12
Day range
$5.97 - $6.21
Year range
$1.26 - $6.46
Market cap
1.87B USD
Avg Volume
1.64M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 616.98M | 1.18% |
Operating expense | 155.09M | 8.76% |
Net income | -98.65M | -2,176.69% |
Net profit margin | -15.99 | -2,152.11% |
Earnings per share | 0.14 | -39.13% |
EBITDA | 138.32M | 0.38% |
Effective tax rate | -11.84% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 93.74M | 237.24% |
Total assets | 3.47B | -8.60% |
Total liabilities | 3.41B | -4.99% |
Total equity | 61.30M | — |
Shares outstanding | 307.01M | — |
Price to book | 102.00 | — |
Return on assets | 5.68% | — |
Return on capital | 7.01% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -98.65M | -2,176.69% |
Cash from operations | 135.82M | 683.13% |
Cash from investing | -31.69M | -176.40% |
Cash from financing | -100.83M | -354.87% |
Net change in cash | 3.50M | 105.77% |
Free cash flow | 106.95M | 375.29% |
About
Amneal Pharmaceuticals, Inc. is an American publicly traded generics and specialty pharmaceutical company. The company is headquartered in Bridgewater, New Jersey. Wikipedia
CEO
Founded
2002
Headquarters
Website
Employees
7,850